Xynomic Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Xynomic Pharma and buy or sell other stocks, ETFs, and their options commission-free!About XYNO
Xynomic Pharma focuses on in-licensing, developing and commercializing oncology drug candidates in China, US, and rest of the world. The founding executives worked at leading multinational biopharmaceutical companies (Schering, Eli Lilly, Merck, and Roche) in R&D roles.
CEOYinglin Mark Xu, MBA
CEOYinglin Mark Xu, MBA
Employees—
Employees—
HeadquartersShanghai, Shanghai
HeadquartersShanghai, Shanghai
Founded2016
Founded2016
Employees—
Employees—
XYNO Key Statistics
Market cap102.73M
Market cap102.73M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.84
52 Week high$3.84
52 Week low$0.2001
52 Week low$0.2001
Stock Snapshot
Xynomic Pharma(XYNO) stock is priced at $2.22, giving the company a market capitalization of 102.73M.
During the trading day, Xynomic Pharma(XYNO) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Xynomic Pharma(XYNO) stock has reached 0.
The stock's 52-week range extends from a low of $0.20 to a high of $3.84.
The stock's 52-week range extends from a low of $0.20 to a high of $3.84.